Novacyt S.A. reiterates revenue guidance of £100 million for the full year 2021, excluding DHSC revenues, as announced on 22 June 2021.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 EUR | -4.76% | +6.67% | +12.20% |
Apr. 19 | Novacyt: confident ahead of DHSC trial | CF |
Apr. 19 | Novacyt expects court to dismiss application by UK DHSC | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.20% | 63.32M | |
-32.64% | 949M | |
-18.52% | 131M | |
+7.32% | 60.9M | |
-16.28% | 61.96M | |
+0.60% | 52.2M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt S.A. Reiterate Revenue Guidance for the Full Year 2021